Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis

Bone marrow mesenchymal stem cells (BM-MSCs) exhibit multiple abnormalities in myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML), including reduced proliferative and clonogenic capacity, altered morphology, impaired immunoregulatory properties and capacity to support hematopoiesis. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Falconi, Giulia, Galossi, Elisa, Fabiani, Emiliano, Pieraccioli, Marco, Travaglini, Serena, Hajrullaj, Hajro, Cerretti, Raffaella, Palmieri, Raffaele, Latagliata, Roberto, Maurillo, Luca, Voso, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732345/
https://www.ncbi.nlm.nih.gov/pubmed/36481766
http://dx.doi.org/10.1038/s41598-022-24644-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732345/
https://www.ncbi.nlm.nih.gov/pubmed/36481766
http://dx.doi.org/10.1038/s41598-022-24644-1

Ejemplares similares